Arizona Gov. Doug Ducey designated $150 million in new funding for the University of Arizona Health Sciences Center for Advanced Molecular and Immunological Therapies, which also received part of a new $10 million gift from the Steele Foundation.
Category Archives: AZBio News
AZ FAST Grants – Apply by Dec 31 2022
FEDERAL AND STATE TECHNOLOGY (FAST) PARTNERSHIP PROGRAM
The Arizona Commerce Authority has partnered with the Small Business Administration to facilitate the SBIR program in Arizona. Arizona’s FAST program provides funds, resources, training, and network opportunities to help entrepreneurs succeed in their SBIR proposal.
Please note: FAST Grant funding is only available to Arizona businesses seeking an SBIR-funded grant. FAST Grant applications are being accepted through December 31, 2022.
C-Path and Eisai Data Sharing Collaboration to Include Lennox-Gastaut Syndrome Registry and Clinical Trial Data
TUCSON, Ariz., Nov. 2, 2022 — Critical Path Institute (C-Path) and the Eisai Co., Ltd. (Eisai) today announced a joint collaboration to significantly promote data sharing and incorporate Lennox-Gastaut Syndrome (LGS) clinical trial data, into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading
Time to Apply for the Flinn Foundation Seed Grants to Promote Translational Research Program
Seed Grants application now open
In 2023, the Flinn Foundation Seed Grants to Promote Translational Research Program will fund up to 10 research teams affiliated with an Arizona university, research institution, or health-care system that are advancing new products or services to improve patient care.Continue reading
CashLabs LLC Acquires Beacon Biomedical Inc.
Phoenix, Ariz. (November 1, 2022) – CashLabs LLC, a Tucson Arizona based national laboratory platform, announced the acquisition of Beacon Biomedical, a Phoenix Arizona based CLIA accredited medical laboratory focused on the development and commercialization of early detection cancer screening tests.Continue reading
Crispr in diagnostics will be a revolution . . . eventually.
Two years ago this month, the Nobel Prize in Chemistry was awarded to two of the pioneers of the Crispr DNA-editing technique. Since then, it has displaced all other laboratory techniques for that purpose by virtue of its accuracy, simplicity, ease of use, and low cost.
How it works and why it was Nobel-worthyContinue reading
BIO and AZBio 2022 Reports Illustrate Bioindustry Impact
The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The report includes individual fact sheets for all 50 states, the District of Columbia and Puerto Rico, which can be found alongside the full report and interactive map at www.bio.org/jobs. AZBio uses this data and additional federally reported data to build its statewide progress report.
C-Path Appoints Neuropharmacology Expert as New Vice President – Rare and Orphan Disease Programs
Dr. Collin Hovinga will lead two public-private partnerships at C-Path — the Rare Disease Cures Accelerator Data and Analytics Platform (RDCA-DAP®) and the Critical Path for Rare Neurodegenerative Diseases (CP-RND).Continue reading
UArizona researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer
University of Arizona researchers have been working for decades to develop a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects.Continue reading